BR112012010445A2 - processo para a preparação de 5-(2-amino-pirimidin-4-il)-2-aril-1 h-pirrol-3-carboxamidas - Google Patents

processo para a preparação de 5-(2-amino-pirimidin-4-il)-2-aril-1 h-pirrol-3-carboxamidas

Info

Publication number
BR112012010445A2
BR112012010445A2 BR112012010445A BR112012010445A BR112012010445A2 BR 112012010445 A2 BR112012010445 A2 BR 112012010445A2 BR 112012010445 A BR112012010445 A BR 112012010445A BR 112012010445 A BR112012010445 A BR 112012010445A BR 112012010445 A2 BR112012010445 A2 BR 112012010445A2
Authority
BR
Brazil
Prior art keywords
pyrrol
pyrimidin
amino
carboxamides
aryl
Prior art date
Application number
BR112012010445A
Other languages
English (en)
Other versions
BR112012010445B1 (pt
Inventor
Marco Re
Matteo D Anello
Original Assignee
Nerviano Medical Sciences Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nerviano Medical Sciences Srl filed Critical Nerviano Medical Sciences Srl
Publication of BR112012010445A2 publication Critical patent/BR112012010445A2/pt
Publication of BR112012010445B1 publication Critical patent/BR112012010445B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)

Abstract

processo para a preparação de 5-(2-amino-pirimidin-4-il)-2-aril-1 h-pirrol-3-carboxamidas. a invenção se refere a um processo para a preparação de 5-(2-amino-pirimidina-4-il)-2-aril-1h-pirrol-3-carboxamidas e aos compostos úteis intermediários de tal processo. o processo permite obter os produtos desejados com elevados níveis de rendimento e pureza. a síntese se inicia a partir de acoplamento de um acetal com um beta-cetoéster, o composto resultante é acetilado e, em seguida, é reagido com um acetal de dialquil de n,n-dimetilformamida para dar um intermediário que é ciclizado para 5-(2-amino-pirimidina-4-il)-2aril-1h-pirrol-3-carbixílico éster; o éster carboxílico é então hidrolisado e o ácido carboxílico resultante é finalmente condensado com uma forma apropriada de amoníaco para dar a carboxamida desejada. os compostos preparados de acordo com o processo da presente invenção são dotados de atividade inibidora da proteína cinase e, mais particularmente, atividade inibidora cdc7 ou cdc7/cdks. os compostos são úteis no tratamento de uma variedade de cancros, doenças proliferativas de células e doenças associadas à proteína cinase.
BR112012010445-4A 2009-11-04 2010-10-27 Processo para a preparação de 5-(2-amtno-pirimidin-4-il)-2-aril-1 h-pirrol-3-carboxamidas BR112012010445B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09175063.8 2009-11-04
EP09175063 2009-11-04
PCT/EP2010/066241 WO2011054714A1 (en) 2009-11-04 2010-10-27 Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1h-pyrrole-3-carboxamides

Publications (2)

Publication Number Publication Date
BR112012010445A2 true BR112012010445A2 (pt) 2015-09-29
BR112012010445B1 BR112012010445B1 (pt) 2021-09-21

Family

ID=43431011

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012010445-4A BR112012010445B1 (pt) 2009-11-04 2010-10-27 Processo para a preparação de 5-(2-amtno-pirimidin-4-il)-2-aril-1 h-pirrol-3-carboxamidas

Country Status (15)

Country Link
US (1) US8592583B2 (pt)
EP (1) EP2496570B1 (pt)
JP (1) JP5715146B2 (pt)
CN (1) CN102666527B (pt)
AR (1) AR078883A1 (pt)
AU (1) AU2010314204B2 (pt)
BR (1) BR112012010445B1 (pt)
CA (1) CA2779785C (pt)
CL (1) CL2012001140A1 (pt)
EA (1) EA021299B1 (pt)
ES (1) ES2593630T3 (pt)
HK (1) HK1175781A1 (pt)
MX (1) MX339634B (pt)
TW (1) TWI478914B (pt)
WO (1) WO2011054714A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012143248A1 (en) * 2011-04-19 2012-10-26 Nerviano Medical Sciences S.R.L. Substituted pyrimidinyl-pyrroles active as kinase inhibitors
CN107915720B (zh) * 2016-10-08 2020-09-11 常州市第四制药厂有限公司 沃诺拉赞的新制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09295967A (ja) * 1996-05-02 1997-11-18 Sumitomo Metal Ind Ltd 新規ピロールアルカン酸誘導体
SE0202463D0 (sv) * 2002-08-14 2002-08-14 Astrazeneca Ab Novel compounds
JP2007519754A (ja) * 2004-01-30 2007-07-19 スミスクライン ビーチャム コーポレーション 化合物
JP5212101B2 (ja) * 2005-09-02 2013-06-19 アステラス製薬株式会社 新規化合物
MX2008012422A (es) * 2006-03-27 2008-10-09 Nerviano Medical Sciences Srl Derivados de furano y tiofeno, pirrol substituido con pirimidinil y piridil como inhibidores de cinasa.
TWI426074B (zh) * 2008-04-30 2014-02-11 Nerviano Medical Sciences Srl ５－（２－胺基－嘧啶－４－基）－２－芳基－１ｈ－吡咯－３－羧醯胺之製造方法

Also Published As

Publication number Publication date
AU2010314204A1 (en) 2012-06-21
WO2011054714A1 (en) 2011-05-12
AU2010314204B2 (en) 2015-03-26
MX2012004844A (es) 2012-06-12
BR112012010445B1 (pt) 2021-09-21
US8592583B2 (en) 2013-11-26
EA021299B1 (ru) 2015-05-29
JP5715146B2 (ja) 2015-05-07
TWI478914B (zh) 2015-04-01
MX339634B (es) 2016-06-02
CA2779785A1 (en) 2011-05-12
CN102666527A (zh) 2012-09-12
TW201121954A (en) 2011-07-01
CL2012001140A1 (es) 2012-08-31
EP2496570A1 (en) 2012-09-12
ES2593630T3 (es) 2016-12-12
AR078883A1 (es) 2011-12-07
CA2779785C (en) 2017-09-12
JP2013510110A (ja) 2013-03-21
EA201290276A1 (ru) 2012-12-28
CN102666527B (zh) 2014-10-01
HK1175781A1 (en) 2013-07-12
EP2496570B1 (en) 2016-06-29
US20120220771A1 (en) 2012-08-30

Similar Documents

Publication Publication Date Title
BR112012021865A2 (pt) derivados de ceto benzofurano, assim com o respectivo processo de síntese e os intermediários.
UY31796A (es) Derivados de ácido ciclopentanocarboxílico condensados sustituidos con acilamino y su uso como productos farmacéuticos.
TR201807740T4 (tr) ATR kinaz inhibitörü olarak 2-amino-6-fluoro-n-(5-fluoro-4-(4-(4-(oksetan-3-il)piperazin-1-karbonil)piperidin-1-il)piridin-3-il)pirazolo[1,5alfa]pirimidin-3-karboksamid.
DOP2012000121A (es) Derivados de acido carboxilico ciclico sustituidos con acilamino y su uso como productos farmaceuticos
BRPI0915692B8 (pt) compostos derivados de 1,2,5-oxadiazóis, sua forma sólida, sua composição, bem como seus usos
TN2012000578A1 (en) Tetrahydro-pyrido-pyrimidine derivatives
PH12015501116A1 (en) New indanyloxydihydrobenzofuranylacetic acids
MX2012013082A (es) Derivados de 2-aminopiridina utiles como iinhibidores de cinasa atr.
MX2012013081A (es) Compuestos utiles como inhibidores de cinasa atr.
MX2011006503A (es) Derivados de pirazina utiles como inhibidores de la cinasa de atr.
MY150596A (en) Hsp90 inhibitors
BR112012032244A2 (pt) processo para preparar derivados de antranilamida com tetrazole-substituído e polimorfos cristalinos novos e derivados destes
BR112013024156A2 (pt) processo de síntese de derivados de cetobenzofurano
BRPI0911634B8 (pt) processo para a preparação de 5-(2-amino-pirimidin-4-il)-2-aril-1h-pirrol-3-carboxamidas
NZ625593A (en) Purine derivatives useful as hsp90 inhibitors
GEP20186885B (en) Novel compounds
AU2009306733C1 (en) Sulfoximine-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as medicine
BR112015012909A2 (pt) compostos de ácido borônico de triazol substituído
ATE517869T1 (de) Herstellung substituierter morphinan-6-one und salzen und zwischenprodukten davon
BR112012017845A2 (pt) novo processo para produção de derivados de benzofenona
EA201300646A1 (ru) Способ получения небиволола
BR112012013582A2 (pt) processo para síntese de intermediários úteis para a produção de compostos de indazol e azaindazol substituídos
BR112017017066A2 (pt) método de preparação para praziquantel e compostos intermediários do mesmo
BR112015015229A8 (pt) processo para a preparação de um composto da fórmula, e, composto
BR112012010445A2 (pt) processo para a preparação de 5-(2-amino-pirimidin-4-il)-2-aril-1 h-pirrol-3-carboxamidas

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/10/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.